Murray CJ
Ortblad KF
Guinovart C
Lim SS
Wolock TM
Roberts DA
Dansereau EA
Graetz N
Barber RM
Brown JC
Wang H
Duber HC
Naghavi M
Dicker D
Dandona L
Salomon JA
Heuton KR
Foreman K
Phillips DE
Fleming TD
Flaxman AD
Phillips BK
Johnson EK
Coggeshall MS
Abd-Allah F
Abera SF
Abraham JP
Abubakar I
Abu-Raddad LJ
Abu-Rmeileh NM
Achoki T
Adeyemo AO
Adou AK
Adsuar JC
Agardh EE
Akena D
Al Kahbouri MJ
Alasfoor D
Albittar MI
Alcala-Cerra G
Alegretti MA
Alemu ZA
Alfonso-Cristancho R
Alhabib S
Ali R
Alla F
Allen PJ
Alsharif U
Alvarez E
Alvis-Guzman N
Amankwaa AA
Amare AT
Amini H
Ammar W
Anderson BO
Antonio CA
Anwari P
Arnlov J
Arsenijevic VS
Artaman A
Asghar RJ
Assadi R
Atkins LS
Badawi A
Balakrishnan K
Banerjee A
Basu S
Beardsley J
Bekele T
Bell ML
Bernabe E
Beyene TJ
Bhala N
Bhalla A
Bhutta ZA
Abdulhak AB
Binagwaho A
Blore JD
Basara BB
Bose D
Brainin M
Breitborde N
Castaneda-Orjuela CA
Catala-Lopez F
Chadha VK
Chang JC
Chiang PP
Chuang TW
Colomar M
Cooper LT
Cooper C
Courville KJ
Cowie BC
Criqui MH
Dandona R
Dayama A
De Leo D
Degenhardt L
Del Pozo-Cruz B
Deribe K
Des Jarlais DC
Dessalegn M
Dharmaratne SD
Dilmen U
Ding EL
Driscoll TR
Durrani AM
Ellenbogen RG
Ermakov SP
Esteghamati A
Faraon EJ
Farzadfar F
Fereshtehnejad SM
Fijabi DO
Forouzanfar MH
Fra Paleo U
Gaffikin L
Gamkrelidze A
Gankpe FG
Geleijnse JM
Gessner BD
Gibney KB
Ginawi IA
Glaser EL
Gona P
Goto A
Gouda HN
Gugnani HC
Gupta R
Gupta R
Hafezi-Nejad N
Hamadeh RR
Hammami M
Hankey GJ
Harb HL
Haro JM
Havmoeller R
Hay SI
Hedayati MT
Pi IB
Hoek HW
Hornberger JC
Hosgood HD
Hotez PJ
Hoy DG
Huang JJ
Iburg KM
Idrisov BT
Innos K
Jacobsen KH
Jeemon P
Jensen PN
Jha V
Jiang G
Jonas JB
Juel K
Kan H
Kankindi I
Karam NE
Karch A
Karema CK
Kaul A
Kawakami N
Kazi DS
Kemp AH
Kengne AP
Keren A
Kereselidze M
Khader YS
Khalifa SE
Khan EA
Khang YH
Khonelidze I
Kinfu Y
Kinge JM
Knibbs L
Kokubo Y
Kosen S
Defo BK
Kulkarni VS
Kulkarni C
Kumar K
Kumar RB
Kumar GA
Kwan GF
Lai T
Balaji AL
Lam H
Lan Q
Lansingh VC
Larson HJ
Larsson A
Lee JT
Leigh J
Leinsalu M
Leung R
Li Y
Li Y
De Lima GM
Lin HH
Lipshultz SE
Liu S
Liu Y
Lloyd BK
Lotufo PA
Machado VM
Maclachlan JH
Magis-Rodriguez C
Majdan M
Mapoma CC
Marcenes W
Marzan MB
Masci JR
Mashal MT
Mason-Jones AJ
Mayosi BM
Mazorodze TT
McKay AC
Meaney PA
Mehndiratta MM
Mejia-Rodriguez F
Melaku YA
Memish ZA
Mendoza W
Miller TR
Mills EJ
Mohammad KA
Mokdad AH
Mola GL
Monasta L
Montico M
Moore AR
Mori R
Moturi WN
Mukaigawara M
Murthy KS
Naheed A
Naidoo KS
Naldi L
Nangia V
Narayan KM
Nash D
Nejjari C
Nelson RG
Neupane SP
Newton CR
Ng M
Nisar MI
Nolte S
Norheim OF
Nowaseb V
Nyakarahuka L
Oh IH
Ohkubo T
Olusanya BO
Omer SB
Opio JN
Orisakwe OE
Pandian JD
Papachristou C
Caicedo AJ
Patten SB
Paul VK
Pavlin BI
Pearce N
Pereira DM
Pervaiz A
Pesudovs K
Petzold M
Pourmalek F
Qato D
Quezada AD
Quistberg DA
Rafay A
Rahimi K
Rahimi-Movaghar V
Ur Rahman S
Raju M
Rana SM
Razavi H
Reilly RQ
Remuzzi G
Richardus JH
Ronfani L
Roy N
Sabin N
Saeedi MY
Sahraian MA
Samonte GM
Sawhney M
Schneider IJ
Schwebel DC
Seedat S
Sepanlou SG
Servan-Mori EE
Sheikhbahaei S
Shibuya K
Shin HH
Shiue I
Shivakoti R
Sigfusdottir ID
Silberberg DH
Silva AP
Simard EP
Singh JA
Skirbekk V
Sliwa K
Soneji S
Soshnikov SS
Sreeramareddy CT
Stathopoulou VK
Stroumpoulis K
Swaminathan S
Sykes BL
Tabb KM
Talongwa RT
Tenkorang EY
Terkawi AS
Thomson AJ
Thorne-Lyman AL
Towbin JA
Traebert J
Tran BX
Dimbuene ZT
Tsilimbaris M
Uchendu US
Ukwaja KN
Uzun SB
Vallely AJ
Vasankari TJ
Venketasubramanian N
Violante FS
Vlassov VV
Vollset SE
Waller S
Wallin MT
Wang L
Wang X
Wang Y
Weichenthal S
Weiderpass E
Weintraub RG
Westerman R
White RA
Wilkinson JD
Williams TN
Woldeyohannes SM
Wong JQ
Xu G
Yang YC
Yano Y
Yentur GK
Yip P
Yonemoto N
Yoon SJ
Younis M
Yu C
Jin KY
El Sayed Zaki M
Zhao Y
Zheng Y
Zhou M
Zhu J
Zou XN
Lopez AD
Vos T
Lancet. 2014;3841005-70
BACKGROUND: The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. METHODS: To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets. FINDINGS: Globally in 2013, there were 1.8 million new HIV infections (95% uncertainty interval 1.7 million to 2.1 million), 29.2 million prevalent HIV cases (28.1 to 31.7), and 1.3 million HIV deaths (1.3 to 1.5). At the peak of the epidemic in 2005, HIV caused 1.7 million deaths (1.6 million to 1.9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19.1 million life-years (16.6 million to 21.5 million) have been saved, 70.3% (65.4 to 76.1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7.5 million (7.4 million to 7.7 million), prevalence was 11.9 million (11.6 million to 12.2 million), and number of deaths was 1.4 million (1.3 million to 1.5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7.1 million (6.9 million to 7.3 million), prevalence was 11.2 million (10.8 million to 11.6 million), and number of deaths was 1.3 million (1.2 million to 1.4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64.0% of cases (63.6 to 64.3) and 64.7% of deaths (60.8 to 70.3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1.2 million deaths (1.1 million to 1.4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31.5% (15.7 to 44.1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. INTERPRETATION: Our estimates of the number of people living with HIV are 18.7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. FUNDING: Bill & Melinda Gates Foundation.
